Ignite injectable stimulus combines an injectable cellular scaffold, demineralized bone matrix (DBM), and aspirated bone marrow. The combination provides a minimally invasive graft with osteoconductive, osteoinductive, and osteogenic capacity.
The Ignite technique may reduce operative time, cost, surgical risks, and morbidity compared to traditional autograft harvesting.1
The combination of DBM and BMA has over a decade of clinical use. This composite has demonstrated clinical success comparable to open, autologous grafting.2